Sinus Dilation Devices include endoscopes (handheld devices), nasal masks, special lenses, cushions, and specially designed oral appliances. These devices are designed to improve patient comfort and remove the stress while increasing the patient's level of mobility. This also includes a range of products that include nasal strips, sprays meant for increased lubrication, relief of pressure on the nasal passages, and clearing of blocked sinuses. Endoscopes too are medical devices that allow doctors to view the openings or abnormalities of the endoscope.
The high prevalence of sinusitis is primarily fueling the growth of sinus dilation devices market. Increasing adoption of minimally invasive surgical procedures for treating sinusitis is again propelling market growth. Continuous product innovation by the key manufacturer in order to meet the rising demand around the globe and improve patient care is further anticipated to foster market growth. Moreover, growing awareness regarding the disease coupled with favorable government policies is also projected to foster the growth of sinus dilation devices market . On the other hand, the risk associated with the sinus surgery post-operative is expected to hinder the growth of the sinus dilation devices market over the forecast period.
North America is projected to gain significant growth over the forecast period and this is attributed to the high prevalence of sinusitis. According to the Sinus & Allergy Wellness Center, at some point in their lives, 11.6% of adults in the United States will receive a sinusitis diagnosis. Sinusitis impacts approximately 30 million adults in the United States every year. Moreover, sinusitis caused Americans 73 million restricted activity days. Also, increasing adoption of advanced medical procedures for treating sinus is further projected to propel the regional market growth.
Key Developments:
In August 2018, Fortis introduces a minimally invasive incision-less technique for sinusitis management
In August 2019, Dalent Medical has announced that it has listed its Sinusleeve balloon sinus dilation device with the FDA.
In April 2018, Acclarent, Inc, part of the Johnson & Johnson Medical Devices Companies* that manufacture minimally-invasive Ear, Nose, & Throat (ENT) technologies, announced the US commercial launch of TruDi, a real-time, three-dimensional (3D) navigation system for ENT procedures performed in the operating room and surgeon’s office
In July 2019, Dalent Medical has closed on a $1.5 million funding round from private investors including the Miami Angels. It will be used to bolster sales for its first patented product, the Sinusleeve balloon; a single-use, disposable sinus dilation device.
No comments:
Post a Comment